All PlansAdministrativeLow impact
Sapropterin (Dr. Reddy's – April)
UPMC Health Plan·Pharmacy, Pediatrics, Genetics·Pharmacy
Effective date
Apr 23, 2024
We identified it
Aug 7, 2026
Summary
Dr. Reddy's Laboratories has recalled six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg due to discolored powder that may reduce drug effectiveness. This is a pharmaceutical product recall affecting patients with phenylketonuria (PKU). Billing teams should be aware that affected patients may experience treatment interruptions or require alternative medications, potentially impacting claims and prior authorizations for this specialty drug.
Action Required
No direct billing action required. This is an informational recall notice. Clinical and pharmacy staff should: (1) Verify patient medication lot numbers against the recall list on the FDA website; (2) Notify affected patients to contact their doctor or pharmacy; (3) Coordinate with providers and Dr. Reddy's (1-866-733-3952) regarding replacement medications or treatment continuations. Billing team should monitor for any authorization delays if patients require alternative PKU therapies during the recall period and be prepared to process claims for substitute medications if prescribed.